Delivery Order SPE2DB22D3016-SPE2DB25FAJR8
Award Date
1/10/25
Potential Completion Date
2/3/25
Potential Value
$22K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,175.20 Firm Fixed Price Delivery Order contract is for the supply of PADCEV 30 MG VIALS, a medical product, with a completion date of February 18, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $24,988.50, is for the delivery of PADCEV 30 MG VIALS, a pharmaceutical product. This is a Firm Fixed Price delivery order contract with a period of performance through December 9, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds...
This federal contract award, valued at $19,999.44, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of PADCEV 30 MG VIALS, a medical product, with a completion date of December 10, 2024. The contract is a Delivery Order under a Firm Fixed Price type, and there is no set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This federal contract award, valued at $2,771.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for PADCEV 30 MG VIALS, with a firm fixed price and an ultimate completion date of March 25, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award, valued at $5,172.68, was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and is a Delivery Order contract with a Firm Fixed Price pricing type. The contract is for the product "PADCEV 30 MG VIALS" and has an ultimate completion date of January 17, 2025. The contract was not designated with a set-aside requirement,...
This federal contract award, with an identifier of SPE2DB22D2206|SPE2DB25FDZ51, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $24,999.30 Firm Fixed Price Delivery Order is for the supply of PADCEV 30 MG VIALS, a pharmaceutical product. The contract has an ultimate completion date of November 20, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal...
This federal contract award, valued at $18,479.50, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PADCEV 20 MG VIALS, a pharmaceutical product, with a completion date of March 25, 2025. The contract is a Firm Fixed Price Delivery Order and was not set aside for any specific business type. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at up to $14,999.58, is for the provision of PADCEV 30 MG VIALS and has a completion date of June 24, 2024. This award appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up...
The federal contract award SPE2DB22D3501|SPE2DB25FUS53 was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the delivery of PADCEV 20 MG vials. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $9,239.75 and an ultimate completion date of March 19, 2025. Amerisourcebergen Drug Corp is a for-profit organization and has an extensive history of federal contract awards,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,087.60, is for the supply of PADCEV 30 MG VIALS medical products. It is a firm fixed-price contract with a completion date of February 4, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...